These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 15194359)

  • 81. Donor factors affecting successful isolation of islets from the human pancreas.
    Watt PC; Mullen Y; Benhamou PY; Hober C; Nomura Y; Watanabe Y; Kleinman R; Miyamoto M; Passaro EP; Zinner MJ
    Transplant Proc; 1994 Apr; 26(2):594-5. PubMed ID: 8171573
    [No Abstract]   [Full Text] [Related]  

  • 82. The effect of donor factors on human islet yield and their in vivo function.
    Sabek OM; Cowan P; Fraga DW; Gaber AO
    Prog Transplant; 2006 Dec; 16(4):350-4. PubMed ID: 17183943
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Improved human islet isolation using a new enzyme blend, liberase.
    Linetsky E; Bottino R; Lehmann R; Alejandro R; Inverardi L; Ricordi C
    Diabetes; 1997 Jul; 46(7):1120-3. PubMed ID: 9200645
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Assessment of six different collagenase-based methods to isolate feline pancreatic islets.
    Zini E; Franchini M; Guscetti F; Osto M; Kaufmann K; Ackermann M; Lutz TA; Reusch CE
    Res Vet Sci; 2009 Dec; 87(3):367-72. PubMed ID: 19386336
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Analysis of donor age and cold ischemia time as factors in cadaveric human islet isolation.
    Ketchum RJ; Nicolae M; Jahr H; Friedman A; Naji A; Barker CF; Brayman KL
    Transplant Proc; 1994 Apr; 26(2):596-7. PubMed ID: 8171574
    [No Abstract]   [Full Text] [Related]  

  • 86. Toward maximizing the success rates of human islet isolation: influence of donor and isolation factors.
    Ponte GM; Pileggi A; Messinger S; Alejandro A; Ichii H; Baidal DA; Khan A; Ricordi C; Goss JA; Alejandro R
    Cell Transplant; 2007; 16(6):595-607. PubMed ID: 17912951
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Evaluation of collagenase gold plus BP protease in isolating islets from human pancreata.
    Khiatah B; Tucker A; Chen KT; Perez R; Bilbao S; Valiente L; Medrano L; Rawson J; Forouhar E; Omori K; Kandeel F; Qi M; Al-Abdullah IH
    Islets; 2018 Mar; 10(2):51-59. PubMed ID: 29381419
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Factors that affect human islet isolation.
    Sakuma Y; Ricordi C; Miki A; Yamamoto T; Pileggi A; Khan A; Alejandro R; Inverardi L; Ichii H
    Transplant Proc; 2008 Mar; 40(2):343-5. PubMed ID: 18374062
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Variables in organ donors that affect the recovery of human islets of Langerhans.
    Lakey JR; Warnock GL; Rajotte RV; Suarez-Alamazor ME; Ao Z; Shapiro AM; Kneteman NM
    Transplantation; 1996 Apr; 61(7):1047-53. PubMed ID: 8623183
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Improved method for the isolation and purification of human islets of langerhans using Liberase enzyme blend.
    Olack BJ; Swanson CJ; Howard TK; Mohanakumar T
    Hum Immunol; 1999 Dec; 60(12):1303-9. PubMed ID: 10626746
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Comparative analysis of collagenase XI and liberase H1 for the isolation of human pancreatic islets.
    Nikolic DM; Djordjevic PB; Sreckovic VD; Paunovic I; Kalezic N; Popovic S; Nikolic B; Stefanovic D
    Hepatogastroenterology; 2010; 57(104):1573-8. PubMed ID: 21443123
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Research-Focused Isolation of Human Islets From Donors With and Without Diabetes at the Alberta Diabetes Institute IsletCore.
    Lyon J; Manning Fox JE; Spigelman AF; Kim R; Smith N; O'Gorman D; Kin T; Shapiro AM; Rajotte RV; MacDonald PE
    Endocrinology; 2016 Feb; 157(2):560-9. PubMed ID: 26653569
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Improved recovery of human islets from young donor pancreases utilizing increased protease dose to collagenase for digesting peri-islet extracellular matrix.
    Loganathan G; Subhashree V; Narayanan S; Tweed B; Goedde MA; Gunaratnam B; Tucker WW; Goli P; Mokshagundam S; McCarthy RC; Williams SK; Hughes MG; Balamurugan AN
    Am J Transplant; 2019 Mar; 19(3):831-843. PubMed ID: 30203908
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Quantitative assessment of islet cell products: estimating the accuracy of the existing protocol and accounting for islet size distribution.
    Buchwald P; Wang X; Khan A; Bernal A; Fraker C; Inverardi L; Ricordi C
    Cell Transplant; 2009; 18(10):1223-35. PubMed ID: 19818209
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Increase of islet yields obtained from human pancreas donor following change of pH value in collagenase digestion medium.
    Lu S; Jaeger C; Wolff-Vorbeck G; Khalaf AN; Kirste G
    Transplant Proc; 1995 Dec; 27(6):3202-4. PubMed ID: 8539914
    [No Abstract]   [Full Text] [Related]  

  • 96. Evidence for a significant correlation of donor pancreas morphology and the yield of isolated purified human islets.
    Mahler R; Franke FE; Hering BJ; Brandhorst D; Brandhorst H; Brendel MD; Federlin K; Schulz A; Bretzel RG
    J Mol Med (Berl); 1999 Jan; 77(1):87-9. PubMed ID: 9930935
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Isoprostanes as markers of oxidative stress-induced cell damage in porcine islet cell isolation.
    Stiegler P; Schaffellner S; Hackl F; Iberer F; Aigner R; Christine B; Tscheliessnigg K; Stadlbauer V
    Transplant Proc; 2010 Jun; 42(5):1618-20. PubMed ID: 20620486
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Islet isolation under cGMP conditions: replacing the coil.
    Garfinkel MR; Connors M; Ostrega D; Jarosz J; Philipson L; Millis JM
    Transplant Proc; 2004 May; 36(4):1031-3. PubMed ID: 15194358
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Combining Donor Characteristics with Immunohistological Data Improves the Prediction of Islet Isolation Success.
    Berkova Z; Saudek F; Girman P; Zacharovova K; Kriz J; Fabryova E; Leontovyc I; Koblas T; Kosinova L; Neskudla T; Vavrova E; Habart D; Loukotova S; Zahradnicka M; Lipar K; Voska L; Skibova J
    J Diabetes Res; 2016; 2016():4214328. PubMed ID: 27803935
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Evaluation of Pefabloc as a serine protease inhibitor during human-islet isolation.
    Rose NL; Palcic MM; Helms LM; Lakey JR
    Transplantation; 2003 Feb; 75(4):462-6. PubMed ID: 12605110
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.